decorative nodes

Updates

May 10, 2021 · The New York Times arrow icon

New York Times Letter to the Editor

The Science & Technology Action Committee's letter to the editor calls for greater funding for the White House Office of Science and Technology Policy (OSTP). This funding is critical for OSTP to have a substantive role in coordinating the cross-agency projects needed to deliver science and technology solutions to some of society’s greatest challenges.

May 8, 2021 · Medium arrow icon

Science: The Vital Piece of the Jobs Plan That Should be Bipartisan

President Biden's $250 billion American Jobs Plan proposal has the potential to make the US more competitive in a global market and better protected against biological and cyber threats of the future.

April 29, 2021

S-TAC Supports Dr. Lander Confirmation, Calls for New Funding for OSTP

The Science and Technology Action Committee today released a statement declaring their support for the confirmation of President Biden’s nominee for the Director of the Office of Science & Technology Policy (OSTP), Dr. Eric Lander.

April 29, 2021

Science Committee Responds to Biden’s Prioritization of Science in First 100 Days

In response to President Biden’s focus on science and technology in the first 100 days of his administration, Keith Yamamoto, Vice Chancellor for Science Policy & Strategy at UCSF and co-chair of the Science and Technology Action Committee, released the following statement on behalf of the Science and Technology Action Committee.

April 2, 2021

Response to American Jobs Plan

Science and technology are critical to our nation’s future, but America invests just 0.7 percent of GDP in R&D today versus 1.9 percent in 1964. The U.S. has fallen to 14th globally in public investment in science and technology as a percentage of GDP. There is, however, a growing recognition that existential societal challenges, as well as maintaining global competitiveness, demand that we dramatically elevate U.S. investment in science and technology.

March 24, 2021 · Morning Consult arrow icon

In the U.S.-China Competition Over Science and Technology, Only One Is In the Running

Competition among scientists and nations could end Alzheimer’s disease, cancer and AIDS, keep our nation technologically secure and help us feed and power the world as we address climate change. But instead of investing in the science and technology to maintain our competitive edge, U.S. investments are waning as China’s advantage has grown.

March 17, 2021 · Wall St Journal Opinion arrow icon

U.S. Must Not Fall Behind China in Research

Falling behind in R&D would hinder our ability to attract top science, technology, engineering and mathematics students and talent from the U.S. and abroad and continue to compete in the global economic arena.

January 20, 2021 · Washington Post Letters to the Editor arrow icon

Opinion: Supporting and funding science at the top is critical

The Jan. 20 news article “Biden to give White House science office Cabinet status” reported on the Biden administration’s plan to elevate the importance of science and technology to tackle the greatest challenges of our time — from food, water and energy security to the threat of further pandemics to climate challenges. President Biden should be lauded for taking this important step, which will bring rigorous scientific thinking to the highest level of government, and he should be congratulated for bringing together top scientific minds to lead the White House science team, including the nomination of Eric Lander to Office of Science and Technology Policy director.

January 19, 2021 · Futurism arrow icon

Here’s How Biden Could Save the Coronavirus Vaccine Rollout

To figure out how he can reach his goals, Futurism asked numerous public health experts how the Biden administration will be able to turn the vaccination campaign around. Here are the steps they outlined.

January 15, 2021 · The Hill arrow icon

The US government’s best ally: Science

One of the greatest scientific achievements of the past century — the rapid development of safe, effective COVID-19 vaccines — happened because the United States broke with convention. A unique public and private sector collaboration, built on the foundations of decades of federal basic science support and fueled by urgency and an infusion of funds, unleashed the best America has to offer.

The Science & Technology Action Committee is a nonpartisan coalition of non-profit, academic, foundation, and corporate leaders advocating to dramatically strengthen science and technology. The Committee is co-chaired by: Keith Yamamoto, Vice Chancellor for Science Policy & Strategy UCSF, Sudip Parikh, CEO, The American Association for the Advancement of Science (AAAS), and Mary Woolley, President & CEO, Research!America.